This is in line with an earlier report linking CD38 enzymatic activity to CLL cell growth,14 while also providing mechanistic insight through selectively down-modulating CD45 activityhi subpopulations. The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.